A skincare manufacturer’s stability lab is where hot-climate risk is either closed out or quietly postponed. Buyers often approve a factory on the strength of a sample that looked fine on the day it arrived — and then spend the next eighteen months managing complaints about color shift, scent drift, leaking pumps, and viscosity that “used to be thicker.” The lab that produces those samples is the same lab that decides whether your product survives a 45 °C container in a Jebel Ali yard, a humid Bangkok warehouse, or a car boot in an Australian summer.
This guide is written for brand owners and sourcing managers who need to evaluate a stability laboratory as a procurement decision, not a personality judgment. Every point below is framed as something you can request, verify, and put in writing before you commit to a mould, a purchase order, or a launch date. It applies to serums, scalp treatments, emulsions, gels, and anhydrous formats sold into the Middle East, Southeast Asia, Africa, and Australia.
60-Second Summary: What a Stability Lab Must Prove for Hot-Climate Skincare
- The trigger is the market, not the formula. High ambient temperature, long supply chains, and non-air-conditioned last-mile delivery turn ordinary oxidation, pigment instability, and seal degradation into consumer-visible failures. A lab that only tests at 25 °C and 60% RH has not tested your market.
- Three decisions come first. (1) Which storage and transport conditions your product must survive, defined numerically; (2) which critical quality attributes you will track — not just appearance; (3) who owns the stability protocol, the raw data, and the shelf-life claim.
- Fastest safe path. Lock the packaging bill of materials and the formula version before testing starts, then run risk assessment, baseline (T0) characterization, accelerated and cycling studies, and preservative efficacy in parallel. Artwork and label claims can be finalized afterwards — they are not on the critical path.
- Request these five items immediately: the written stability protocol with conditions and timepoints; T0 raw data for pH, viscosity, appearance, color, odor, and weight loss; the real-container compatibility report; the preservative efficacy test report with its method reference; and the change-control procedure covering raw material and packaging supplier changes.
- Do not accept “no separation after three months at high temperature” as a shelf-life justification. That is one attribute at one condition. Shelf life is supported by the full attribute set across all relevant conditions and, ultimately, by real-time data.
Informational only, not legal advice. Confirm market-specific obligations with your regulatory specialist.
Decision Tree: Which Evaluation Path Fits Your Project?
- Start here. If the product is a new SKU in a new package → require a full written protocol plus real-container compatibility testing before any stability claim is discussed.
- If you are reusing a proven formula but changing the bottle, pump, liner, or label material → treat it as a packaging change: re-run compatibility and orientation (inverted/side-lay) testing, but full long-term stability may be reduced to confirmatory timepoints.
- If you are changing a fragrance, a botanical extract supplier, the preservative, or a carrier system → treat it as a formula change: stability re-test is required and preservative efficacy must be re-assessed. Assume the existing shelf life is no longer supported until proven otherwise.
- If the SKU is anhydrous, alcohol-based, or “water-free” → do not skip microbiological risk assessment. Absence of water lowers risk; it does not eliminate it, and raw-material bioburden still counts.
- If you intend to claim “clinically proven,” “dermatologist tested,” or “hypoallergenic” → require finished-product evidence on the formula and package you will sell, not a raw-material study and not a single patch test.
- If the product will sit in non-temperature-controlled distribution for more than two weeks → add transport simulation and cycling to the protocol, and obtain written shipping-condition guidance for your cartons.
- Boundary cases. Step outside the normal path when: the formula contains oxidation-prone actives or natural extracts with variable color; the pack uses a metal spring, silicone valve, or soft-touch coating in contact with the product; the target market requires a specific safety or efficacy dossier; or an out-of-specification result has already occurred. In those cases bring in specialist regulatory counsel and expand the test matrix before you scale.
Stability Risk Assessment Comes Before Any Test Chamber
A competent lab does not hand you a fixed test table. It runs a risk assessment first and uses the output to justify the conditions, timepoints, and attributes it will track. Ask to see that assessment. It should be built from six inputs:
- Dosage form — emulsion, transparent aqueous, surfactant system, anhydrous, or suspension. This predicts whether you are fighting separation, crystallization, volatilization, or microbial ingress.
- Formula — pH, electrolytes, polymers, oils, actives, fragrance load, and preservative system. These define the sensitive points.
- Packaging — material, seal design, pump or spray function, moisture-vapor transmission, and the potential for back-flow contamination during use.
- Transport — the realistic maximum and minimum temperatures, vibration, and orientation changes your cartons will experience.
- Use pattern — bathroom storage, high-frequency cap opening, finger dipping, dropper or pump use. This drives in-use contamination risk.
- Market — climate, regulatory requirements, labeling rules, and supply-chain length, which together define the scope of validation.
If a supplier sends a generic “3 months at 40 °C, passed” certificate with no assessment behind it, you are looking at a testing vendor, not a stability function.
What to Ask Your Manufacturer: Minimum Evidence Pack
A) Compliance, filings, and site qualification
- Request: Current GMP certificate and the audit scope statement for the manufacturing site.
Evidence: ISO 22716:2007 certificate (still the current published version) or an equivalent national GMP certificate such as the NMPA cosmetics GMP, with site name, scope, issuing body, and expiry date.
Owner: Manufacturer.
Acceptance criteria: Site name on the certificate matches the site name on the COA and the batch record; scope covers the product type; certificate is valid at the planned production date.
- Request: Market notification and responsible-person arrangement for each destination.
Evidence: Filing references and the name of the legal entity holding each notification, plus confirmation of who maintains the product information file.
Owner: Buyer (with manufacturer documentation support).
Acceptance criteria: Every target market has a named holder and a reference number issued before first shipment.
- Request: Safety Data Sheet and full ingredient declaration aligned to the formula version.
Evidence: SDS in the required language and format, plus an INCI list that matches the approved formula line by line.
Owner: Manufacturer.
Acceptance criteria: Zero discrepancies between the SDS ingredient list, the INCI on artwork, and the formula record.
B) Testing and substantiation
- Request: The written stability protocol before the first sample is made.
Evidence: Protocol document listing dosage form rationale, storage conditions, timepoints (for example 0, 1, 3, 6, 12, 24, 36 months where applicable), test attributes, methods, acceptance criteria, and packaging orientation.
Owner: Manufacturer.
Acceptance criteria: Conditions map to your defined worst-case market temperature; attributes include pH, viscosity, appearance, color, odor, weight loss, and package function — not appearance alone.
- Request: T0 baseline data package that becomes your reference profile.
Evidence: Raw results at release for every tracked attribute, with method identifiers and instrument records.
Owner: Lab.
Acceptance criteria: Baseline is tied to a named formula version and process version, and to a reference image or data archive you can compare against later.
- Request: Accelerated, cycling, freeze-thaw, and light-exposure results.
Evidence: Full reports with raw data, not pass/fail summaries, including any excursion notes.
Owner: Lab.
Acceptance criteria: Reports state the condition, duration, timepoint, attribute, result, and acceptance limit for every measurement.
- Request: Preservative efficacy test report.
Evidence: Challenge test report citing the method used, the organisms, the sampling schedule, and the acceptance criteria.
Owner: Lab.
Acceptance criteria: Test performed on the current formula version; written commitment that a fragrance, botanical, or preservative change triggers re-assessment.
- Request: Microbiological specification and testing plan, including bulk hold-time validation.
Evidence: Specification sheet, test methods, and a hold-time study covering semi-finished bulk stored before filling.
Owner: Manufacturer / Lab.
Acceptance criteria: Bulk hold time is validated for the actual maximum interval your production plan allows.
C) Labeling and claims guardrails
- Request: A claims substantiation file, one entry per on-pack claim.
Evidence: For each claim: the exact wording, the test or study supporting it, the population or conditions tested, and the report reference.
Owner: Buyer / Manufacturer regulatory.
Acceptance criteria: No claim ships without a named evidence document; “clinically proven” is supported by finished-product data, not raw-material data.
- Request: Written position on high-risk terms.
Evidence: Internal guidance on “hypoallergenic,” “dermatologist tested,” “sensitive skin suitable,” “natural,” and “chemical-free,” with the market-specific evidence each requires.
Owner: Manufacturer regulatory / Buyer.
Acceptance criteria: Each term is either supported by documented evidence or removed from artwork before print.
- Request: Storage and transport statement for a hot market.
Evidence: Draft label text plus a written shipping-condition recommendation for your cartons and pallets.
Owner: Manufacturer / Buyer.
Acceptance criteria: Statement is consistent with the conditions actually tested, and the claim is not contradicted by your distribution reality.
D) QA, traceability, and audit readiness
- Request: A sample Certificate of Analysis and the template behind it.
Evidence: COA showing product, SKU, batch, manufacture date, specification and acceptance limits, test methods, results with units, and an authorized quality release signature.
Owner: Manufacturer.
Acceptance criteria: No result appears on a COA that was not actually tested, and every value is traceable to a batch record.
- Request: The out-of-specification and out-of-trend procedure.
Evidence: A written SOP describing immediate hold of affected lots, parallel laboratory and manufacturing investigations, impact-lot assessment, and disposition authority.
Owner: Manufacturer.
Acceptance criteria: The SOP triggers investigation on trend signals, not only on final failures, and includes a documented hold step.
- Request: Change-control procedure for raw materials and packaging.
Evidence: SOP plus a worked example showing that a supplier change triggered stability re-test and preservative re-assessment.
Owner: Manufacturer.
Acceptance criteria: The example shows a real change, a documented impact assessment, and a signed restart decision.
- Request: Retention sample and chamber monitoring records.
Evidence: Retention policy with controlled storage location and timepoint plan for commercial batches, plus continuous temperature and humidity logs with excursion handling.
Owner: Manufacturer.
Acceptance criteria: Logs show no unexplained excursion; retention plan extends across the declared shelf life.
Evidence Pack Summary
- Written stability protocol with market-specific conditions, timepoints, attributes, and acceptance criteria.
- T0 baseline data set tied to formula version and process version, with archived raw data or reference images.
- Accelerated, cycling, freeze-thaw, and light-exposure reports containing raw data.
- Real-container compatibility report covering bottle, pump, gasket, liner, and label.
- Preservative efficacy test report with method reference and re-test trigger statement.
- Microbiological specification plus validated bulk hold-time study.
- COA template and one completed example with batch, method, limits, and release signature.
- OOS/OOT SOP with hold, dual investigation, and impact-lot assessment.
- Change-control SOP with a worked supplier-change example.
- Claims substantiation file with one evidence document per on-pack claim.
- Retention sample policy and chamber temperature/humidity monitoring logs.
- GMP certificate and site scope statement matching the manufacturing site.
The Red Lines: What You Do Not Cut to Hit a Launch Date
- Do not convert accelerated data into a shelf-life number. High-temperature storage is a screening and supporting tool; it is not a multiplier. Real-time data supports the claim.
- Do not judge stability on appearance alone. pH drift, viscosity change, odor shift, weight loss, and pump function must be measured at every timepoint.
- Do not ship a formula whose fragrance, botanical, preservative, or carrier has changed without stability re-test and preservative re-assessment. A new botanical supplier can change both chemical composition and microbial load.
- Do not accept a COA without batch identity, specification limits, methods, and a release signature. An untraceable COA is a documentation gap, not a quality record.
- Do not lock the formula before real-container testing is complete. Lab glass is not a pump bottle, and a pump bottle in a hot car is not a lab.
- Do not release a batch with an unresolved microbiological out-of-specification result. Hold it, investigate the laboratory and the manufacturing line in parallel, and assess affected lots.
- Do not accept “clinically proven” based on a raw-material study. The evidence must describe the finished product, the population, the endpoint, and the result.
The Golden Stability Profile: What “Reliable” Actually Means
Ask your manufacturer to define, in writing, a reference profile for each SKU. It is the benchmark every future stability result is compared against, and it makes drift visible before it becomes a complaint.
| Baseline element |
What it should state |
Red flag |
| Formula and process version |
Named version identifiers tied to the batch record |
Results reported without a version reference |
| T0 target values |
Measured pH, viscosity, appearance, color, odor, fill weight at release |
Targets quoted as ranges from a brief, not measured data |
| Expected trend |
Documented normal drift per attribute over shelf life |
No trend expectation; only a pass/fail limit |
| Acceptable range |
SKU specification limits with units and method |
Limits that differ between COA and stability report |
| Alert threshold |
Trend deviation that triggers investigation before failure |
Investigations opened only after an out-of-specification result |
| Reference archive |
Retained images, raw data files, and retained samples |
No archived reference material to compare against |
Test Conditions Are Not a Universal Table
Each condition answers a different question, and each has a boundary. Ask the lab to explain which condition exists for which risk in your product.
| Condition |
What it is for |
Boundary to state in the protocol |
| Long-term / target storage |
Primary shelf-life evidence against real storage conditions |
Must correspond to the declared market storage environment |
| Elevated temperature |
Screening for separation, color shift, odor change, viscosity drift |
Cannot be converted to real-time months by a fixed multiplier |
| Low temperature |
Crystallization, clouding, pump and rheology behavior |
Particularly relevant for oil, surfactant, and polymer systems |
| Freeze-thaw and thermal cycling |
Repeated stress at interfaces and structures during transit |
Applied where the route or season creates real risk, not universally |
| Light exposure |
Color, fragrance, and active degradation in transparent packs |
Required where the pack transmits light or the formula is photo-sensitive |
| Centrifuge |
Rapid screening during development |
Never a substitute for long-term stability |
| Transport and vibration |
Package and content behavior through the distribution channel |
Must be run jointly with the packaging module |
Packaging Compatibility: The Half of Stability Nobody Tests
Many hot-climate complaints are not formula failures at all. They are interface failures: a gasket that swells at 45 °C, a pump that loses prime when viscosity drops, a label adhesive that lifts in humidity, or a fragrance component that interacts with a plastic liner and discolors the product over three months.
- Require testing with the real bottle, real pump, real gasket, and the final surface decoration — not a laboratory surrogate.
- Require inverted and side-lay storage as standard timepoints for liquid formats.
- Require fill weight and weight-loss tracking to detect moisture vapor transmission and volatilization.
- Require function testing at each timepoint: pump strokes to prime, dose weight, leakage, cap torque, and label adhesion.
- Require a written conclusion that names the material, the specification, the supplier, and the allowed tolerance that were locked.
Timeline: Two Realistic Paths
The two paths below differ in what you compress, not in what you skip. Real-time shelf-life studies continue in the background in both cases.
| Phase |
Fastest safe path |
Standard path |
Evidence produced at exit |
| 1. Risk assessment and protocol approval |
Week 1–2, run in parallel with formula selection |
Week 1–3, with formal sign-off |
Approved protocol with conditions, timepoints, and attributes |
| 2. Packaging bill of materials lock and T0 baseline |
Week 2–3, single packaging source only |
Week 2–5, with a secondary source qualified |
T0 data package and locked packaging specification |
| 3. Accelerated, cycling, and light studies |
Week 3–10, reduced timepoint set |
Week 3–14, full timepoint set |
Interim and final stability reports with raw data |
| 4. Preservative efficacy and microbiological testing |
Week 3–8, started at day one |
Week 3–12, including bulk hold-time study |
Challenge test report and micro specification |
| 5. Claims review and artwork lock |
Week 8–10 |
Week 10–16 |
Signed claims substantiation file and approved artwork |
| 6. Pilot run and engineering verification |
Week 10–12 |
Week 14–20 |
Pilot batch record and filled-container verification report |
| 7. Documentation handoff and retention program |
Week 12–13 |
Week 20–24 |
COA set, SDS, stability report, retention plan, change-control commitment |
What may be compressed: the number of interim timepoints in accelerated studies, artwork review cycles, and the sequencing of parallel tests. What may not be compressed: T0 characterization, real-container compatibility, preservative efficacy, and the hold-and-investigate discipline around any out-of-trend signal.
Common Failure Modes: Symptom to Request
1. Color deepens in transit (packaging and heat interaction)
- Symptom: Consumers report the product arrived darker than the website image, typically in summer shipments.
- Root cause: Oxidation, pigment or natural-extract instability, insufficient thermal or light protection, and uncontrolled transport conditions.
- Prevention: Run elevated-temperature, cycling, and light-exposure studies on the finished pack; consider opaque or light-blocking packaging; define and communicate shipping conditions.
- What to request from factory (Evidence): Stability report with instrumented color measurement across timepoints, plus a written shipping-condition recommendation.
2. Leaking or failing pump after heat exposure (packaging compatibility failure)
- Symptom: Seepage at the collar, pump losing prime, dose weight dropping, or the actuator sticking after a few weeks in a warm warehouse.
- Root cause: Gasket or valve material swelling, viscosity drop changing pump performance, or a tolerance mismatch between bottle neck and closure.
- Prevention: Test the real pack in inverted and side-lay orientation at elevated temperature, with function testing at every timepoint and a documented material specification.
- What to request from factory (Evidence): Real-container compatibility report naming the gasket and valve materials, dose-weight data across timepoints, and a leakage/vibration test record.
3. “It didn’t separate” but the texture changed
- Symptom: No visible splitting, yet consumers say the serum feels thinner or no longer suspends.
- Root cause: Stability judged on appearance only; viscosity, pH, and rheology were never tracked.
- Prevention: Fix the attribute list in the protocol and measure every attribute at every timepoint.
- What to request from factory (Evidence): Viscosity and pH trend tables with method identifiers and specification limits.
4. Microbiological out-of-specification in a stability sample
- Symptom: A stability timepoint returns a microbial result outside specification.
- Root cause: Preservative system inadequate for the actual formula, raw-material bioburden, water or equipment contamination, or an in-use ingress path.
- Prevention: Immediate hold of the sample and all potentially affected lots; parallel laboratory investigation and manufacturing investigation; impact-lot assessment; documented disposition.
- What to request from factory (Evidence): Hold notice, investigation reports from both lab and manufacturing, affected-lot list, and the final disposition record.
5. Out-of-trend signals ignored until they become failures
- Symptom: Results drift steadily for two timepoints, then fail. The failure appears sudden in the report.
- Root cause: The quality system only reacts to out-of-specification results, with no alert threshold for trends.
- Prevention: Define alert thresholds in the reference profile and require investigation at the trend stage.
- What to request from factory (Evidence): OOT procedure and at least one worked example showing an investigation opened before failure.
6. Botanical extract supplier change with no re-test (documentation and change-control failure)
- Symptom: A new supplier of a plant extract is introduced; the product is released with the previous stability and challenge test reports.
- Root cause: Change control covers only the purchase order, not the impact on chemical stability, preservative efficacy, and shelf life.
- Prevention: Trigger a formal impact assessment for any raw material supplier change, covering stability re-test, preservative efficacy reassessment, microbiological specification review, packaging impact, and shelf-life validity.
- What to request from factory (Evidence): Completed change assessment form, re-test protocol, and a signed restart decision for long-term studies.
7. Incomplete or mismatched COA (documentation failure)
- Symptom: The COA arrives without a batch code, without methods, with limits that differ from the specification, or with an INCI list that does not match the artwork.
- Root cause: A template copied across SKUs, no release authorization step, and no reconciliation between formula record and label copy.
- Prevention: Require a controlled COA template and a three-way reconciliation of formula record, SDS, and artwork INCI before print.
- What to request from factory (Evidence): COA template, one completed example with release signature, and a signed reconciliation checklist.
8. Shelf life extrapolated from a single accelerated condition
- Symptom: A 36-month shelf life is printed after three months at elevated temperature with no separation.
- Root cause: Mechanical application of an acceleration factor and disregard for other critical attributes.
- Prevention: Base the claim on the full attribute set across all relevant conditions, supported by real-time data and a defined reference profile.
- What to request from factory (Evidence): Shelf-life justification document citing which data supports which claim period, plus the real-time study plan.
Copy-Paste Supplier Request Checklist
Confirm target markets and the worst-case ambient temperature range for each.
Share dosage form, formula version, and full packaging bill of materials.
Request the written stability protocol before any sample is produced.
Verify conditions, timepoints, attributes, and acceptance limits in that protocol.
Attach the packaging specification, including pump, gasket, valve, and label material.
Ask for T0 baseline data with method identifiers and archived reference images.
Request accelerated, cycling, freeze-thaw, and light reports with raw data.
Require inverted and side-lay orientation timepoints for liquid formats.
Confirm viscosity, pH, odor, color, weight loss, and pump function are tracked.
Ask for the preservative efficacy report and its method reference.
Confirm in writing that fragrance, botanical, or preservative changes trigger re-test.
Request the microbiological specification and the bulk hold-time study.
Provide the final artwork copy for INCI and claims reconciliation.
Request one evidence document per on-pack claim.
Remove any claim lacking a named supporting document.
Ask for the OOS and OOT procedure, including hold and impact-lot assessment.
Request the change-control SOP with one worked supplier-change example.
Request the COA template and one completed example with release signature.
Confirm the retention sample policy and controlled storage location.
Request chamber temperature and humidity logs, including excursion records.
Verify the GMP certificate site name matches the COA and batch record.
Confirm who holds each market notification and product information file.
Lock formula version, packaging specification, and supplier tolerances in writing.
Approve pilot run only after compatibility and efficacy results are reviewed.
Schedule the documentation handoff and the real-time study review dates.
Summary Table: Leverage Points and Red Lines
| Lever / Decision |
Primary impact |
What to do (specific) |
Do NOT cut (red line) |
Evidence needed (request) |
Expected timeline effect |
| Define market conditions first |
Prevents testing against the wrong climate |
Write the maximum and minimum storage and transit temperatures per destination into the protocol brief |
Elevated-temperature testing matched to the declared market range |
Approved protocol citing market conditions |
Adds 1–2 weeks upfront; avoids a full re-test later |
| Lock packaging bill of materials early |
Removes the largest source of hot-climate complaints |
Freeze bottle, pump, gasket, and label supplier plus tolerances before stability starts |
Real-container compatibility testing in final orientation |
Compatibility report naming materials and dose-weight trends |
Adds 2–3 weeks; prevents post-launch pack change |
| Fix the attribute list |
Turns appearance-only testing into real evidence |
Specify pH, viscosity, odor, color, weight loss, and function at every timepoint |
Instrumented color and viscosity measurement with methods |
Timepoint trend tables with limits |
No added time; prevents false “stable” conclusions |
| Run risk assessment before testing |
Focuses budget on actual failure risks |
Document dosage form, formula, pack, transport, use, and market inputs |
A written risk assessment signed before the first sample |
Risk assessment document with condition rationale |
Saves 1–3 weeks of unnecessary conditions |
| Start preservative efficacy at day one |
Avoids the most common release blocker |
Commission the challenge test in parallel with T0 characterization |
Preservative efficacy testing on the current formula version |
Challenge test report with method and organism list |
Saves 3–4 weeks versus sequential testing |
| Govern change control |
Protects the shelf-life claim after launch |
Require impact assessment for any raw material or packaging supplier change |
Stability re-test and efficacy reassessment on supplier change |
Change assessment form and restart decision |
Adds days per change; prevents recalls |
| Substantiate claims before artwork |
Avoids label reprints and market rejections |
Map every claim to one evidence document and delete unsupported terms |
Finished-product evidence for efficacy and tolerability claims |
Claims substantiation file |
Adds 2 weeks; avoids full artwork reprint |
| Demand traceable documentation |
Makes audits and complaints manageable |
Reconcile formula record, SDS, COA, and artwork INCI in one review |
Batch-level COA with limits, methods, and release signature |
COA template, example, and reconciliation checklist |
Adds 3–5 days; prevents shipment holds |
| Set up retention and real-time studies |
Defends the shelf-life claim over time |
Place commercial batch retention samples in controlled storage with a fixed timepoint plan |
Controlled-environment retention across the declared shelf life |
Retention policy and chamber monitoring logs |
Runs in background; protects future SKUs |
FAQ
How long does stability testing take before a hot-climate launch?
A compressed but defensible program typically takes 10–13 weeks from protocol approval to documentation handoff, provided packaging is locked and preservative efficacy testing starts immediately. A lower-risk standard path runs 20–24 weeks. Real-time shelf-life studies continue well beyond either date and should be planned as an ongoing commitment, not a launch gate.
Can we skip real-time testing if accelerated results pass?
No. Accelerated and cycling conditions are screening and supporting tools that reveal risk early. They do not convert into a shelf-life number through a fixed multiplier. The declared shelf life needs real-time data generated against your defined storage conditions, together with a reference profile you can compare future batches against.
Who should own the stability protocol — us or the manufacturer?
The manufacturer or its laboratory should draft it, but you should approve it. The protocol defines the conditions your product is being judged against, which is a commercial decision as much as a technical one. Keep a copy, and make sure it names the formula version and packaging specification so the results stay traceable to what you actually sell.
Do we need to re-test if we change the fragrance or a botanical extract supplier?
Yes. A fragrance or botanical change can shift chemical stability, color, odor, and microbial load, and it can affect how well the preservative system performs. Treat it as a formula change: stability re-test is required, preservative efficacy must be re-assessed, and the existing shelf life should be considered unsupported until the new data says otherwise.
What is the difference between “no separation” and “stable”?
“No separation” is a single observation about one attribute at one point in time. “Stable” means every critical attribute — appearance, color, odor, pH, viscosity, weight, package function, and microbiological status — stayed within defined limits across all relevant conditions, and the trend matched what the reference profile predicted. Accept the second definition in writing, or you are buying an opinion.
Next Step
If you are evaluating a stability laboratory for a hot-climate skincare launch, send the manufacturer a structured brief rather than a general enquiry. Quotes move fastest when you include target markets, SKU count and formats, brand positioning, packaging direction, and your timeline target — those five inputs let a laboratory price the protocol, the compatibility work, and the efficacy testing accurately instead of guessing.
Bring your brief, your packaging direction, and your claims list to the team and ask for a protocol outline before you ask for a price. Request a Quote and include your market list and target launch date so the stability scope can be sized against your actual distribution reality.
Informational only, not legal advice. Regulatory obligations vary by market and should be confirmed with a qualified specialist for your destination countries.
LAEYO
Hi, I'm your LAEYO representative, hope you like this blog post.
With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.